TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Paronychia Drugs Market, Global Outlook and Forecast 2023-2030

Paronychia Drugs Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 18 November 2023
  • Pages :69
  • Formats:
  • Report Code:SMR-7853709

The global Paronychia Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
 

Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.
This report aims to provide a comprehensive presentation of the global market for Paronychia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paronychia Drugs.

This report contains market size and forecasts of Paronychia Drugs in global, including the following market information:
Global Paronychia Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)

The Americas account for a major share in the global paronychia treatment market owing to the increasing prevalence of acute paronychia, chronic paronychia, candidal paronychia, and pyogenic paronychia.
We surveyed the Paronychia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paronychia Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Type, 2022 (%)

  • Mupirocin Ointment
  • Fusidic Acid Ointment
  • Gentamicin Ointment
  • Dicloxacillin
  • Others

Global Paronychia Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Application, 2022 (%)

  • Hospitals
  • Clinics
  • Dermatology Center
  • Others

Global Paronychia Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Paronychia Drugs Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Paronychia Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Paronychia Drugs revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • GlaxoSmithKline
  • Teva Pharmaceutical
  • Eli Lilly
  • Fougera Pharmaceuticals
  • Taro Pharmaceutical Industries
  • Glenmark Generics
  • Jonakayem Pharma Formulation

Outline of Major Chapters:
Chapter 1: Introduces the definition of Paronychia Drugs, market overview.
Chapter 2: Global Paronychia Drugs market size in revenue.
Chapter 3: Detailed analysis of Paronychia Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Paronychia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Paronychia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Paronychia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Paronychia Drugs Overall Market Size
2.1 Global Paronychia Drugs Market Size: 2022 VS 2030
2.2 Global Paronychia Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Paronychia Drugs Players in Global Market
3.2 Top Global Paronychia Drugs Companies Ranked by Revenue
3.3 Global Paronychia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Paronychia Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Paronychia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Paronychia Drugs Players in Global Market
3.6.1 List of Global Tier 1 Paronychia Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Paronychia Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Paronychia Drugs Market Size Markets, 2022 & 2030
4.1.2 Mupirocin Ointment
4.1.3 Fusidic Acid Ointment
4.1.4 Gentamicin Ointment
4.1.5 Dicloxacillin
4.1.6 Others
4.2 By Type - Global Paronychia Drugs Revenue & Forecasts
4.2.1 By Type - Global Paronychia Drugs Revenue, 2018-2023
4.2.2 By Type - Global Paronychia Drugs Revenue, 2024-2030
4.2.3 By Type - Global Paronychia Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Paronychia Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Dermatology Center
5.1.5 Others
5.2 By Application - Global Paronychia Drugs Revenue & Forecasts
5.2.1 By Application - Global Paronychia Drugs Revenue, 2018-2023
5.2.2 By Application - Global Paronychia Drugs Revenue, 2024-2030
5.2.3 By Application - Global Paronychia Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Paronychia Drugs Market Size, 2022 & 2030
6.2 By Region - Global Paronychia Drugs Revenue & Forecasts
6.2.1 By Region - Global Paronychia Drugs Revenue, 2018-2023
6.2.2 By Region - Global Paronychia Drugs Revenue, 2024-2030
6.2.3 By Region - Global Paronychia Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Paronychia Drugs Revenue, 2018-2030
6.3.2 US Paronychia Drugs Market Size, 2018-2030
6.3.3 Canada Paronychia Drugs Market Size, 2018-2030
6.3.4 Mexico Paronychia Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Paronychia Drugs Revenue, 2018-2030
6.4.2 Germany Paronychia Drugs Market Size, 2018-2030
6.4.3 France Paronychia Drugs Market Size, 2018-2030
6.4.4 U.K. Paronychia Drugs Market Size, 2018-2030
6.4.5 Italy Paronychia Drugs Market Size, 2018-2030
6.4.6 Russia Paronychia Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Paronychia Drugs Market Size, 2018-2030
6.4.8 Benelux Paronychia Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Paronychia Drugs Revenue, 2018-2030
6.5.2 China Paronychia Drugs Market Size, 2018-2030
6.5.3 Japan Paronychia Drugs Market Size, 2018-2030
6.5.4 South Korea Paronychia Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Paronychia Drugs Market Size, 2018-2030
6.5.6 India Paronychia Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Paronychia Drugs Revenue, 2018-2030
6.6.2 Brazil Paronychia Drugs Market Size, 2018-2030
6.6.3 Argentina Paronychia Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Paronychia Drugs Revenue, 2018-2030
6.7.2 Turkey Paronychia Drugs Market Size, 2018-2030
6.7.3 Israel Paronychia Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Paronychia Drugs Market Size, 2018-2030
6.7.5 UAE Paronychia Drugs Market Size, 2018-2030
7 Paronychia Drugs Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Paronychia Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Paronychia Drugs Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Paronychia Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Paronychia Drugs Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Paronychia Drugs Major Product Offerings
7.3.4 Eli Lilly Paronychia Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Fougera Pharmaceuticals
7.4.1 Fougera Pharmaceuticals Company Summary
7.4.2 Fougera Pharmaceuticals Business Overview
7.4.3 Fougera Pharmaceuticals Paronychia Drugs Major Product Offerings
7.4.4 Fougera Pharmaceuticals Paronychia Drugs Revenue in Global Market (2018-2023)
7.4.5 Fougera Pharmaceuticals Key News & Latest Developments
7.5 Taro Pharmaceutical Industries
7.5.1 Taro Pharmaceutical Industries Company Summary
7.5.2 Taro Pharmaceutical Industries Business Overview
7.5.3 Taro Pharmaceutical Industries Paronychia Drugs Major Product Offerings
7.5.4 Taro Pharmaceutical Industries Paronychia Drugs Revenue in Global Market (2018-2023)
7.5.5 Taro Pharmaceutical Industries Key News & Latest Developments
7.6 Glenmark Generics
7.6.1 Glenmark Generics Company Summary
7.6.2 Glenmark Generics Business Overview
7.6.3 Glenmark Generics Paronychia Drugs Major Product Offerings
7.6.4 Glenmark Generics Paronychia Drugs Revenue in Global Market (2018-2023)
7.6.5 Glenmark Generics Key News & Latest Developments
7.7 Jonakayem Pharma Formulation
7.7.1 Jonakayem Pharma Formulation Company Summary
7.7.2 Jonakayem Pharma Formulation Business Overview
7.7.3 Jonakayem Pharma Formulation Paronychia Drugs Major Product Offerings
7.7.4 Jonakayem Pharma Formulation Paronychia Drugs Revenue in Global Market (2018-2023)
7.7.5 Jonakayem Pharma Formulation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Paronychia Drugs Market Opportunities & Trends in Global Market
Table 2. Paronychia Drugs Market Drivers in Global Market
Table 3. Paronychia Drugs Market Restraints in Global Market
Table 4. Key Players of Paronychia Drugs in Global Market
Table 5. Top Paronychia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Paronychia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Paronychia Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Paronychia Drugs Product Type
Table 9. List of Global Tier 1 Paronychia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Paronychia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Paronychia Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Paronychia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Paronychia Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Paronychia Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Paronychia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Paronychia Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Paronychia Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Paronychia Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Paronychia Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Paronychia Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Paronychia Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Paronychia Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Paronychia Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Paronychia Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Paronychia Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Paronychia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Paronychia Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Paronychia Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Paronychia Drugs Revenue, (US$, Mn), 2024-2030
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Paronychia Drugs Product Offerings
Table 32. GlaxoSmithKline Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Teva Pharmaceutical Company Summary
Table 35. Teva Pharmaceutical Paronychia Drugs Product Offerings
Table 36. Teva Pharmaceutical Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Paronychia Drugs Product Offerings
Table 40. Eli Lilly Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Fougera Pharmaceuticals Company Summary
Table 43. Fougera Pharmaceuticals Paronychia Drugs Product Offerings
Table 44. Fougera Pharmaceuticals Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Fougera Pharmaceuticals Key News & Latest Developments
Table 46. Taro Pharmaceutical Industries Company Summary
Table 47. Taro Pharmaceutical Industries Paronychia Drugs Product Offerings
Table 48. Taro Pharmaceutical Industries Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Taro Pharmaceutical Industries Key News & Latest Developments
Table 50. Glenmark Generics Company Summary
Table 51. Glenmark Generics Paronychia Drugs Product Offerings
Table 52. Glenmark Generics Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Glenmark Generics Key News & Latest Developments
Table 54. Jonakayem Pharma Formulation Company Summary
Table 55. Jonakayem Pharma Formulation Paronychia Drugs Product Offerings
Table 56. Jonakayem Pharma Formulation Paronychia Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Jonakayem Pharma Formulation Key News & Latest Developments
List of Figures
Figure 1. Paronychia Drugs Segment by Type in 2022
Figure 2. Paronychia Drugs Segment by Application in 2022
Figure 3. Global Paronychia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Paronychia Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Paronychia Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Paronychia Drugs Revenue in 2022
Figure 8. By Type - Global Paronychia Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Paronychia Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Paronychia Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Paronychia Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Paronychia Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Paronychia Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Paronychia Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Paronychia Drugs Revenue Market Share, 2018-2030
Figure 16. US Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Paronychia Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Paronychia Drugs Revenue Market Share, 2018-2030
Figure 28. China Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Paronychia Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Paronychia Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Paronychia Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. GlaxoSmithKline Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fougera Pharmaceuticals Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Taro Pharmaceutical Industries Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Glenmark Generics Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jonakayem Pharma Formulation Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount